Common Contracts
3 similar At-the-Market Sales Agreement contracts by Inmune Bio, Inc., Mediaco Holding Inc., Suro Capital Corp.
MEDIACO HOLDING INC. UP TO $2,031,019 OF CLASS A COMMON STOCK ($0.01 par value per share) AT-THE-MARKET SALES AGREEMENTAt-the-Market Sales Agreement • December 13th, 2024 • Mediaco Holding Inc. • Radio broadcasting stations • New York
MediaCo Holding Inc., an Indiana corporation (the “Company”), confirms its agreement (this “Agreement”) with BTIG, LLC (“BTIG”) and Moelis & Company LLC (“Moelis”, and, together with BTIG, the “Agents”) as set forth below. The Company, BTIG and Moelis are referred to collectively herein as the “Parties”.
INMUNE BIO INC. UP TO $75,000,000 OF COMMON STOCK (par value $0.001 per share) AMENDED & RESTATED At-the-market SALES AGREEMENTAt-the-Market Sales Agreement • August 9th, 2024 • Inmune Bio, Inc. • Biological products, (no disgnostic substances) • New York
INmune Bio Inc., a Nevada corporation ( the “Company”), confirms its agreement (this “Agreement”) with RBC Capital Markets, LLC (“RBC”) and BTIG, LLC (“BTIG”), each as sales agent and/or principal (each, an “Agent” and together, the “Agents”) as follows. This Agreement amends and restates in its entirety that certain At-The-Market Sales Agreement, dated March 10, 2021, by and between the Company and BTIG, as amended.
At-the-market SALES AGREEMENTAt-the-Market Sales Agreement • August 3rd, 2020 • Suro Capital Corp. • New York